TrianglePUBLICATIONS · 36455187
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Apr 1
- First author
- Itzykson R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Itzykson R
- type
- Author
- name
- Santini V
- type
- Author
- name
- Thepot S
- type
- Author
- name
- Ades L
- type
- Author
- name
- Chaffaut C
- type
- Author
- name
- Giagounidis A
- type
- Author
- name
- Morabito M
- type
- Author
- name
- Droin N
- type
- Author
- name
- Lübbert M
- type
- Author
- name
- Sapena R
- type
- Author
- name
- Nimubona S
- type
- Author
- name
- Goasguen J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Itzykson R
- type
- Author
- name
- Santini V
- type
- Author
- name
- Thepot S
- type
- Author
- name
- Ades L
- type
- Author
- name
- Chaffaut C
- type
- Author
- name
- Giagounidis A
- type
- Author
- name
- Morabito M
- type
- Author
- name
- Droin N
- type
- Author
- name
- Lübbert M
- type
- Author
- name
- Sapena R
- type
- Author
- name
- Nimubona S
- type
- Author
- name
- Goasguen J
- type
- Author
- bibliography ids
- nci-bib-83a5bcd8b84f57c08e8fd178
- book metadata
- content sha256
- 772654a9853fccf3f287c143f04fa5be4413b4b335f2d177c424494eb00b53b5
- document type
- citation
- dois
- 10.1200/JCO.22.00437
- electronic publication date
- display
- 2022 Dec 1
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36455187
- immutable id
- pubmed:36455187@772654a9853fccf3f287c143f04fa5be4413b4b335f2d177c424494eb00b53b5
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1888-1897
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36455187
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 8fe9dc4b32169bb682537f815c828e3c92c8e880488bbfbbdb8fd32812048e9e
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Apr 1
- precision
- day
- year
- 2023
- publication types
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
Preserved source evidence · Not medical advice